McKesson names new independent directors to board

SAN FRANCISCO —McKesson has elected Donald R. Knauss and Susan Salka as new independent directors, effective Oct. 20, bringing the size of the board of directors to 11.



“Don and Susan are both terrific additions to the McKesson Board,” stated John H. Hammergren, chairman and CEO, McKesson Corp. “Don will bring strong international business management and retail expertise, while Susan brings a deep understanding of emerging trends in healthcare services. The addition of Don and Susan to the Board reflects our ongoing commitment to refreshing and strengthening the diversity of our Board and maintaining industry-leading governance practices.”



Knauss has served as chairman and CEO of The Clorox Co. since October 2006. Beginning Nov. 20, he will serve as chairman only, in a newly created executive chairman role. He was EVP of The Coca-Cola Co. and president and COO for Coca-Cola North America from February 2004 until September 2006. Prior to his employment with The Coca-Cola Co., he held various positions in marketing and sales with PepsiCo and Procter & Gamble and served as an officer in the United States Marine Corps. He is also a director of the Kellogg Co. and a member of the board of trustees of both Morehouse College and the University of San Diego. He was formerly a director of URS Corp.



Salka has served as CEO and president of AMN Healthcare Services since 2005, and a director of the company since 2003. She has served in several other executive roles since joining the company in 1990, including COO, CFO and SVP of business development. Salka is also a director of The Campanile Foundation at San Diego State University. She was formerly a director of Beckman Coulter, Playtex Products, University of California San Diego’s Sulpizio Cardiovascular Center and the BIOCOM Institute.



The Board has appointed Knauss and Salka as members of its Audit Committee and its Governance Committee.